Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs.
暂无分享,去创建一个
[1] T. Spector,et al. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics. , 1991, Biochemical pharmacology.
[2] A. Pesce,et al. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. , 1991, Transplantation.
[3] N. White,et al. Clinical Pharmacokinetics of Mefloquine , 1990, Clinical pharmacokinetics.
[4] A. Björkman,et al. Comparison of the activity in vitro of mefloquine and two metabolites against Plasmodium falciparum. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] D. Back,et al. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. , 1989, British journal of clinical pharmacology.
[6] J. Bauchet,et al. Divided-dose kinetics of mefloquine in man. , 1989, British journal of clinical pharmacology.
[7] D. Back,et al. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. , 1988, British journal of clinical pharmacology.
[8] L. Shipley,et al. Disposition of the antimalarial, mefloquine, in the isolated perfused rat liver. , 1988, Biochemical pharmacology.
[9] N. Sonino. The use of ketoconazole as an inhibitor of steroid production. , 1987, The New England journal of medicine.
[10] B. K. Park,et al. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. , 1987, British journal of clinical pharmacology.
[11] G. Farrell,et al. Effects of primaquine on hepatic microsomal haemoproteins and drug oxidation. , 1986, Toxicology.
[12] I. Cockburn. Cyclosporine A: a clinical evaluation of drug interactions. , 1986, Transplantation proceedings.
[13] A. Breckenridge,et al. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. , 1985, British journal of clinical pharmacology.
[14] H. Webster,et al. Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand. , 1985, The American journal of tropical medicine and hygiene.
[15] N. White. Clinical Pharmacokinetics of Antimalarial Drugs , 1985, Clinical pharmacokinetics.
[16] D. Back,et al. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure‐activity relationship , 1985, British journal of pharmacology.
[17] K. Speeg,et al. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[18] M. Brown,et al. Effect of ketoconazole on hepatic oxidative drug metabolism , 1985, Clinical pharmacology and therapeutics.
[19] D. Back,et al. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine. , 1985, Biochemical pharmacology.
[20] A. Breckenridge,et al. The effects of primaquine stereoisomers and metabolites on drug metabolism in the isolated perfused rat liver and in vitro rat liver microsomes. , 1985, Biochemical pharmacology.
[21] M. Murray. In vitro effects of quinoline derivatives on cytochrome P-450 and aminopyrine N-demethylase activity in rat hepatic microsomes. , 1984, Biochemical pharmacology.
[22] B. K. Park,et al. Effect of chloroquine and primaquine on antipyrine metabolism. , 1983, British journal of clinical pharmacology.
[23] A. Breckenridge,et al. Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat. , 1983, Biochemical pharmacology.
[24] H. Webster,et al. TYPE II MEFLOQUINE RESISTANCE IN THAILAND , 1982, The Lancet.
[25] D. E. Schwartz,et al. Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man. , 1980, Acta tropica.
[26] N. Molek,et al. The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[27] P. Dayton,et al. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[28] M. Dixon. The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.
[29] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[30] N. White,et al. CLINICAL IMPORTANCE OF ANTIMALARIAL PHARMACOKINETICS , 1988 .
[31] P. Heizmann,et al. Single-dose kinetics of mefloquine in Brazilian male subjects. , 1987, Bulletin of the World Health Organization.
[32] W. Meuldermans,et al. Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsomes. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.
[33] D. Back,et al. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro. , 1986, Chemico-biological interactions.